%PDF-1.3
%
7 0 obj
<>>>/BBox[0 0 612 792]/Length 142>>stream
x wF-4V;9 7r|廻bءYzyЅ'= &c ,iٸ=L1c Ľ}=wF"2=͂ge]O,b.
endstream
endobj
8 0 obj
<>>>/BBox[0 0 612 792]/Length 142>>stream
x wF-4V;9 7r|廻bءYzyЅ'= &c ,iٸ=L1c Ľ}=wF"2=͂ge]O,b.
endstream
endobj
5 0 obj
<>>>/BBox[0 0 612 792]/Length 142>>stream
x wF-4V;9 7r|廻bءYzyЅ'= &c ,iٸ=L1c Ľ}=wF"2=͂ge]O,b.
endstream
endobj
4 0 obj
<>>>/BBox[0 0 612 792]/Length 142>>stream
x wF-4V;9 7r|廻bءYzyЅ'= &c ,iٸ=L1c Ľ}=wF"2=͂ge]O,b.
endstream
endobj
6 0 obj
<>>>/BBox[0 0 612 792]/Length 142>>stream
x wF-4V;9 7r|廻bءYzyЅ'= &c ,iٸ=L1c Ľ}=wF"2=͂ge]O,b.
endstream
endobj
3 0 obj
<>>>/BBox[0 0 612 792]/Length 142>>stream
x wF-4V;9 7r|廻bءYzyЅ'= &c ,iٸ=L1c Ľ}=wF"2=͂ge]O,b.
endstream
endobj
1 0 obj
<>>>/BBox[0 0 612 792]/Length 142>>stream
x wF-4V;9 7r|廻bءYzyЅ'= &c ,iٸ=L1c Ľ}=wF"2=͂ge]O,b.
endstream
endobj
10 0 obj
<>stream
Arbortext Advanced Print Publisher 9.0.114/W
2022-04-29T10:48:46-07:00
2022-03-12T07:38:04+05:30
application/pdf
SCD-2021-0317-ver9-Wu_4P 1..7
Acrobat Distiller 8.1.0 (Windows); modified using iText 4.2.0 by 1T3XT
uuid:fcf7d3c4-882f-49c6-9b7a-ba0075722fed
uuid:d64bd9e6-ff4c-4a79-b677-4b67fa3c7c47
endstream
endobj
11 0 obj
<>stream
x+ |
endstream
endobj
12 0 obj
<>stream
xS**T0T0 Bi ye(
endstream
endobj
13 0 obj
<>stream
x+ |
endstream
endobj
14 0 obj
<>stream
xS**T0T0 Bi yA$
endstream
endobj
15 0 obj
<>stream
x+ |
endstream
endobj
16 0 obj
<>stream
xS**T0T0 Bi y\'
endstream
endobj
17 0 obj
<>stream
x+ |
endstream
endobj
18 0 obj
<>stream
xS**T0T0 Bi yn)
endstream
endobj
19 0 obj
<>stream
x+ |
endstream
endobj
20 0 obj
<>stream
xS**T0T0 Bi yJ%
endstream
endobj
21 0 obj
<>stream
x+ |
endstream
endobj
22 0 obj
<>stream
xS**T0T0 Bi yS&
endstream
endobj
23 0 obj
<>stream
x+ |
endstream
endobj
24 0 obj
<>stream
xS**T0T0 Bi y8#
endstream
endobj
26 0 obj
<>stream
/GS1 gs
BT
/F4 1 Tf
10.9389 0 0 10.9389 62.022 724.3652 Tm
0 0 0 rg
0 Tc
0 Tw
[(for)-352.5(chondrogenic)-349.7(fate)-357.8(specication)-353.2(from)-348.9(hiPSCs.)-353.8(To)-352.7(achieve)-356.8(native-like)-350.9(stratied)-354.1(cartilage)-350.5(organization)-352.3(with)]TJ
0 -1.0936 TD
[(cartilagebon)6.5(e)-257.8(interaction)6.7(s,)-256.4(spatiotemp)8(oral)-253(cues)-257.8(mimicking)-250.3(develop)8.3(ment)-255.9(can)-254.1(be)-255.4(delivere)7.1(d)-256.7(t)0(o)-255.5(engineered)-246.9(tissues)]TJ
T*
[(by)-337.1(patterning)-340.5(of)-338.3(the)-337.2(cells,)-339.7(scaffold,)-338.5(and)-341(environme)8(nt.)-337.2(Once)-339.4(healthy)-340.2(and)-341(native-li)8.1(ke)-343.5(cartilageb)6.8(one)-341(tissues)-336.8(are)]TJ
T*
[(established,)-354.4(an)-353.9(OA-like)-355.1(state)-356.5(can)-357.8(be)-359(induced)-349.3(through)-353.3(cytokine)-353.3(challenge)-353.2(or)-359(injurious)-352(loading.)-353.4(Bioengi)8.3(neered)]TJ
T*
[(cartilagebon)6.5(e)-335.6(tissues)-326.4(fall)-332(short)-333.2(of)-327.9(recapitulating)-330.5(the)-332(full)-330.9(complexity)-327.9(of)-327.9(native)-332.3(tissues,)-330.4(but)-330.8(have)-329.4(demonstrat)8.2(ed)]TJ
T*
[(utility)-315.9(in)-317.7(elucidating)-318.7(some)-317.7(mechanism)8.2(s)-319.8(o)0(f)-322.7(O)0(A)-315.8(progression)-316.6(and)-315.1(enabled)-319.3(screening)-316.6(of)-317.6(candidate)-316.9(therapeutics)-318.2(in)]TJ
0 -1.0884 TD
[(patient-speci)6.9(c)-387.4(models.)-380.3(With)-380.2(rapid)-380.1(progress)-379.7(in)-385.1(stem)-381.2(cells,)-381.2(tissue)-379.8(engineering,)-378.2(imaging,)-378.2(and)-382.5(high-throughput)]TJ
0 -1.0935 TD
[(omics)-477.2(research)-475.5(in)-478.4(recent)-478.4(years,)-478.1(we)-483.1(propose)-473.3(that)-476(advanced)-477.4(human)-474.9(tissue)-478.2(models)-474.8(will)-481(soon)-473.1(offer)-479.5(valuable)]TJ
T*
[(contributions)-323.9(to)-333.3(our)-330.7(understanding)-327.6(and)-330.7(treatment)-327.5(of)-333.1(OA.)]TJ
/F7 1 Tf
0 -2.1871 TD
(Keywords:)Tj
/F4 1 Tf
4.9909 0 TD
[(osteoarthri)7(tis,)-331.9(chondrogenesis,)-324.8(osteogenesis,)-330.9(tissue)-327.9(engineering,)-331.5(stem)-329.4(cells)]TJ
/F6 1 Tf
9.9626 0 0 9.9626 62.022 550.9983 Tm
[(Ost)-7(eoarthriti)-11.8(s)-330(and)-336.9(Cart)-9.4(ilage)]TJ
/F4 1 Tf
26.1167 0 0 26.1167 61.5118 516.9825 Tm
(A)Tj
/F8 1 Tf
9.843 0 0 9.843 81.2409 527.8676 Tm
[(lthough)-391.1(osteoarthritis)]TJ
/F4 1 Tf
11.3293 0 TD
[(\(OA\))-392(is)-388(the)-384.7(most)-391.5(common)]TJ
-11.3293 -1.1174 TD
[(joint)-357.2(disease)-362.3(affecting)-359.2(over)-356.9(500)-354.6(million)-360.8(people)-360.4(world-)]TJ
-1.9525 -1.1116 TD
[(wide,)-200.1(it)-198.3(remains)-195.5(a)-198.1(chronic)-200.2(degenerative)-203.6(condition)-195.8(with)-201.4(poorly)]TJ
T*
[(understood)-213.7(etiology)-212(and)-211.8(pathology.)-210.6(OA)-211.3(prevalence)-212.8(increased)]TJ
0 -1.1174 TD
[(by)-422.7(nearly)-418(50%)-424.8(between)-421.1(1990)-419.1(and)-419.2(2020)-419.1(and)-424.9(is)-416.8(further)-423.6(in-)]TJ
0 -1.1116 TD
[(creasing)-288.7(in)-278.8(our)-285.5(aging)-283.3(population)-283.3([1].)-283.1(Short)-281.9(of)-284.4(surgical)-287.6(inter-)]TJ
T*
[(ventions,)-261.1(OA)-263.1(management)-260.2(is)-261.3(generally)-261.3(focused)-263.2(on)-255.6(analgesia)]TJ
0 -1.1174 TD
[(with)-731.3(paracetamol,)-731.3(nonsteroidal)-735.7(anti-inammatory)-732.3(drugs)]TJ
0 -1.1116 TD
[(\(NSAIDs\),)-285.1(opioids,)-281.9(and)-280.9(intra-articular)-286.6(corticosteroids.)]TJ
1.0137 -1.1116 TD
[(Repurposing)-1004.9(disease-modifying)-1008.3(antirheumatic)-1005.6(drugs)]TJ
-1.0137 -1.1116 TD
[(\(DMARDs\))-623.6(for)-619.5(rheumatoid)-619.6(arthritis)-621.9(\(RA\))-616.8(showed)-624.7(little)]TJ
0 -1.1174 TD
[(success)-442.6(with)-443.3(OA,)-439.4(and)-442.2(none)-443.3(of)-439.9(the)-442.3(disease-modifying)-443.8(OA)]TJ
0 -1.1116 TD
[(drugs)-350.9(\(DMOADs\))-347(have)-352.3(successfully)-350.4(completed)-349(clinical)-352.6(tri-)]TJ
T*
[(als)-240.5([2].)-242.8(The)-241.8(decit)-239.4(of)-238.3(meaningful)-245.2(OA)-240.1(management)-242.9(strategies)]TJ
0 -1.1174 TD
[(is)-238.3(due,)-244(at)-239.6(least)-244(in)-238.5(part,)-239.5(to)-238.5(the)-240.7(lack)-243(of)-238.3(high-delity)-245.1(models)-239.3(that)]TJ
0 -1.1116 TD
[(would)-432.7(help)-437.7(understand)-433.7(disease)-437.2(progression)-433.4(and)-436.4(test)-437.6(novel)]TJ
T*
[(treatments)-338.4([3].)]TJ
1.0137 -1.1174 TD
-.0156 Tc
[(Heal)-15.6(t)10.7(h).6(y)-379.6(h)-15.6(u)11(man)-379.6(ar)-15.6(t)10.9(i).5(cu)-15.6(l)10.9(a)-.6(r)-379.5(c)-.6(a)-15.6(r)9.9(til)-15.6(a)9.7(g).6(e)-380.7(h).6(a)-15.6(s)-370.1(a)-380.7(s).8(p)-15.6(e)9.8(cic)-386.5(stra)-15.6(t)9.7(i).5(c)-15.6(a)8.7(-)]TJ
-1.0137 -1.1116 TD
-.0158 Tc
[(ti)-15.8(o)10.7(n)-339.4(\(su)-15.8(p)10.8(er)-15.8(c)9.8(ial,)-341.8(tr)-15.8(a)9.7(n).4(si)-15.8(t)10.5(i).3(on)-15.8(a)9.6(l).3(,)-341.8(d).4(eep,)-341.8(a)-.8(nd)-345.2(calci)-15.8()10.8(e)-.8(d)-339.4(z)-.8(on)-15.8(e)9.6(s).6(\),)-341.8(wi)-15.8(t)10.5(h)]TJ
T*
[(eac)-15.8(h)-410.8(l).3(ayer)-425.8(havin)-15.8(g)-409.7(dist)-15.8(i)10.5(n).4(ct)-420.2(c)-15.8(e)8.5(ll)-420.2(and)-420.1(m)-.8(a)-15.8(t)9.5(rix)-420.1(p)-15.8(r)10.8(ope)-15.8(r)9.7(ties)-425.6(\().4(chon)-15.8(-)]TJ
T*
[(dr)-15.8(o)10.8(c)-.8(yte)-369.4(p).4(h)-15.8(e)9.6(not)-15.8(y)10.7(p).4(e,)-370.6(colla)-15.8(g)9.6(e)-.8(n)-368.2(a)-.8(li)-15.8(g)10.7(n).4(ment)-15.8(,)-354.5(an)-15.8(d)-352.1(p)-15.8(r)10.8(o).4(teo)-15.8(g)10.8(lyc)-15.8(a)8.5(n-t)-15.8(o)10.7(-)]TJ
0 -1.1174 TD
-.0159 Tc
[(wat)-15.9(e)9.4(r)-264.6(r).3(atio)-15.9(\))-248.5(t)-15.9(h)10.6(a)-.9(t)-264.8(a)-.9(re)-265.8(esse)-15.9(n)9.5(tial)-264.8(t).2(o)-264.7(its)-264.5(fun)-15.9(c)9.5(tio)-15.9(n)10.7(.)-261.2(Fr)-15.9(i)10.6(c)-.9(tio)-15.9(n)-248.5(a)-.9(n)-15.9(d)-248.5(we)-15.9(a)8.4(r)]TJ
0 -1.1116 TD
-.0156 Tc
[(pr)-15.6(o)11(p).6(er)-15.6(t)10.9(i).5(es)-390.9(at)-391.2(th)-15.6(e)-376.1(a)-15.6(r)9.9(tic)-15.6(u)9.8(l).5(ar)-391(su)-15.6(r)11(f).6(ac)-15.6(e)-377.2(a)-15.6(r)9.9(e)-392.2(enhan)-15.6(c)9.8(ed)-391.1(by)-391.1(the)-392.2(c)-.6(o)-15.6(m)9.8(-)]TJ
T*
0 Tc
[(p)16.2(o)0(s)26.8(i)16.1(t)16.1(i)0(o)26.5(n)16.2(a)15(l)-427.4(h)16.2(e)15(t)16.1(e)15(ro)26.6(g)16.2(e)15(ne)25.4(i)16.1(t)16.1(y)-427.3(o)16.2(f)-421.5(ca)24.3(r)16.2(t)16.1(i)16.1(l)0(a)25.3(g)16.2(e)-422.7([)0(4)26.6(])16.2(,)-423.9(w)15.3(hi)26.5(l)16.1(e)-422.7(th)26.5(e)-422.7(c)15(al)25.3(c)15(i)16.1(e)25.6(d)]TJ
0 -1.1174 TD
-.0158 Tc
[(zon)-15.8(e)-347.5(f)-15.8(e)9.7(atur)-15.8(e)9.7(s)-362.3(smal)-15.8(l)-346.6(c)-.8(h)-15.8(o)10.8(ndr)-15.8(o)10.8(c)-.8(yt)-15.8(e)9.5(s)-356.5(i)-15.8(n)-346.4(t)-15.8(h)10.7(e)-363.6(a)-.8(pati)-15.8(t)10.5(e)-.8(-)-15.8(l)10.8(l).3(ed)-362.5(matr)-15.8(i)10.7(x,)]TJ
0 -1.1116 TD
-.016 Tc
[(wh)-16(i)10.5(c)-1(h)-420.3(l)-16(i)10.3(m)-1(its)-425.8(tr)-16(a)9.5(n).2(sp)-16(o)10.6(r).2(t)-426.2(from)-427.3(the)-427.2(under)-16(l)10.5(yin)-16(g)-409.9(bo)-16(n)10.6(e)-421.4([)-16(5)10.6(].)-422.6(Whi)-16(l)10.3(e)]TJ
T*
-.0158 Tc
[(car)-15.8(t)10.7(ila)-15.8(g)9.6(e)-496.1(i)-15.8(s)-484.5(d)-15.8(e)9.6(void)-500.7(o).4(f)-500.7(v).4(as)-15.8(c)9.8(u).4(la)-15.8(r)9.7(i).3(zat)-15.8(i)10.5(on,)-503(inner)-15.8(v)10.8(ati)-15.8(o)10.7(n,)-497.3(o)-15.8(r)-484.5(ly)-15.8(m)9.6(-)]TJ
0 -1.1174 TD
-.016 Tc
[(ph)-16(a)9.4(tics)-16(,)-296.8(its)-310.6(inte)-16(r)9.5(act)-16(i)10.3(ons)-310.6(with)-310.8(the)-312(s).4(ub)-16(c)9.4(hond)-16(r)10.6(a)-1(l)-311(bone)-312(play)-310.8(a)-306.2(r).2(o)-16(l)10.5(e)]TJ
0 -1.1116 TD
0 Tc
[(i)16.1(n)-317.9(de)25.4(v)16.2(e)15(l)16.1(o)0(p)26.6(m)15(e)15(n)16.2(t,)-304.2(h)16.2(o)0(m)25.4(e)15(o)16.2(s)16.4(ta)25.3(s)16.4(i)16.1(s,)-303.8(an)25.4(d)-317.9(d)16.2(i)16.1(s)0(e)25.6(a)15(s)16.4(e)-319([6)26.6(])16.2(.)]TJ
1.0137 -1.1116 TD
[(In)-422.6(joint)-426.4(diseases,)-424.2(cartilage)-429.6(degeneration)-432.8(progresses)-427.4(in)-422.8(a)]TJ
-1.0137 -1.1174 TD
[(layer-dependent)-362.4(manner.)-353.4(OA)-355.3(typically)-352.6(starts)-353.2(with)-356.9(small)-353.5(le-)]TJ
0 -1.1116 TD
[(sions)-529.4(in)-532.2(the)-528.7(supercial)-532.8(layers,)-536.4(and)-528.6(compensatory)-536.2(matrix)]TJ
T*
[(production)-323.4(from)-322.3(the)-321.4(deeper)-326.8(layers,)-323.3(until)-322.7(the)-321.4(calcied)-330.3(layers)]TJ
T*
[(wear)-531.7(away)-537.5(to)-532.2(expose)-532.9(bone.)-533.1(In)-526.3(addition,)-537.9(pathogenesis)-535(is)]TJ
0 -1.1174 TD
[(mediated)-601.3(by)-595.4(disruptions)-593.8(in)-595.6(tissue)-595.1(cross)-599.5(talk)-593.3(at)-596.7(the)-597.8(os-)]TJ
0 -1.1116 TD
[(teochondral)-338.4(interface)-337.3([7,8].)]TJ
1.0137 -1.1116 TD
[(Mouse)-456.6(models)-458.2(are)-454.8(often)-456(used)-454.6(to)-457.3(study)-454.7(OA,)-456.6(yet)-459.6(fail)-455(to)]TJ
-1.0137 -1.1174 TD
[(recapitulate)-267.2(key)-263.6(aspects)-264.4(of)-261.4(human)-267.1(cartilage)-262.6(anatomy)-264.8(such)-264.6(as)]TJ
0 -1.1116 TD
[(size,)-516.9(thickness,)-516.6(and)-511.3(zonal)-514.8(organizatio)-10.2(n)-507.9([9].)-513.5(Although)-516.8(rat)]TJ
T*
[(models)-354.5(display)-354.5(thicker)-350.1(cartilage)-354.7(with)-356.9(zonal)-353.5(structure,)-349.7(natu-)]TJ
0 -1.1174 TD
[(rally)-427.4(occurring)-421.2(OA)-424.4(is)-422.6(uncommon)-427.1(in)-422.8(rats)-420.2([10].)-422.5(In)-422.6(general,)]TJ
0 -1.1116 TD
[(animals)-558.5(cannot)-562(fully)-552.9(mimic)-556.6(human)-560.8(biology)-555.1(or)-555.1(serve)-560.5(as)]TJ
T*
[(patient-specic)-327.7(models)-320(of)-319(disease,)-325.4(which)-324.5(leads)-318.8(to)-319.1(clinically)]TJ
0 -1.1174 TD
[(inconsistent)-338.2(therapeutics.)]TJ
/F6 1 Tf
9.9626 0 0 9.9626 313.0582 550.9983 Tm
[(Cel)-8.2(l)-333.6(Sour)-8.6(ces)-335.7(for)-335.3(Engin)-10.7(eered)-338.2(Cartilag)-11.3(eBone)]TJ
0 -1.2007 TD
[(Mod)-10.3(els)]TJ
/F4 1 Tf
9.843 0 0 9.843 323.0361 521.2345 Tm
[(With)-398.6(advances)-404.9(in)-394(stem)-398.4(cell)-398.7(and)-396.1(tissue)-399.3(engineering,)-405.2(car-)]TJ
-1.0137 -1.1174 TD
[(tilagebone)-413.4(in)-405.5(vitro)-408.9(tissue)-410.8(models)-412.1(could)-404.2(serve)-410.8(as)-412.1(a)-405.4(viable)]TJ
0 -1.1116 TD
[(alternative)-362.8(because)-357.8(of)-353.5(their)-358.2(biological)-353.7(delity)-354.7(and)-355.8(incorpo-)]TJ
T*
[(ration)-261.4(of)-261.4(human)-261.3(cells)-261.3(and)-257.9(disease-initiating)-266.9(factors.)-261(To)-262.6(build)]TJ
T*
[(patient-specic)-460.2(models)-452.4(that)-455.1(can)-449.1(captu)-8(re)-446.8(disease)-460.2(heteroge-)]TJ
0 -1.1174 TD
[(neity)-554.1(while)-549.2(minimizing)-550.8(clinical)-554.2(invasiveness,)-549.7(human)-549.3(in-)]TJ
0 -1.1116 TD
[(duced)-364.9(pluripotent)-359.4(stem)-358.1(cells)-365(\(hiPSCs\))-360.7(are)-356.9(an)-360.5(advantageous)]TJ
T*
[(choic)-8(e)-330.6(a)0(s)-337.2(they)-334(can)-333.9(be)-331.7(derived)-338.4(from)-333.9(small)-336.3(blood)-333.9(samples.)]TJ
1.0137 -1.1174 TD
[(Primary)-539.9(articular)-543.6(chondrocytes,)-544.2(a)-537.9(mature)-540.2(primary)-540.1(cell)]TJ
-1.0137 -1.1116 TD
[(source,)-346.2(can)-339.7(be)-343.2(harvested)-341.6(from)-339.6(arthroscopic)-345(biopsies)-343.9(of)-336.2(low)]TJ
T*
[(weight-bear)-10.9(ing)-579.4(joint)-581.9(regions)-579(for)-585(autologous)-582.5(chondrocyte)]TJ
0 -1.1174 TD
[(implantati)-9.5(on)-301.7(therapies)-312.9(\(eg,)-307.4(Carticel,)-310.9(MACI\))-313.5([11].)-307.3(However,)]TJ
0 -1.1116 TD
[(their)-248.8(use)-246.2(is)-244(limited)-246.8(by)-244.1(donor)-247.4(site)-247.5(morbidity,)-245.3(dedifferentiation)]TJ
T*
[(after)-445.6(extended)-438.7(in)-440.1(vitro)-437.7(expan)-7.8(sion,)-434(and)-442.2(potentially)-441.3(inferior)]TJ
0 -1.1174 TD
[(function)-338.5(due)-332.8(to)-336.4(patient)-333(age)-333.9(or)-336.2(disease.)]TJ
1.0137 -1.1116 TD
[(While)-279.9(bone)-276.3(marrow)-280.5(\(BM\)-derived)-282.4(mesenchymal)-278.4(stromal/)]TJ
-1.0137 -1.1116 TD
[(stem)-473.3(cells)-474.4(\()-81.7(MSCs\))-473.6(have)-473.3(traditionally)-472.4(been)-473.3(used)-471.9(for)-469.8(their)]TJ
T*
[(musculoskel)-9.8(etal)-364.1(differentiation)-371.9(potential,)-367.5(they)-362.8(have)-363.8(limited)]TJ
0 -1.1174 TD
[(expan)-7.8(sion)-373(capability.)-381.3(In)-370.8(contrast,)-377.5(hiPSCs)-375.9(can)-380(be)-377.7(expanded)]TJ
0 -1.1116 TD
[(near)-703.6(indenitely,)-697.9(allowing)-696.6(for)-700.2(sufcient)-697.5(cell)-698.2(numbers,)]TJ
T*
[(multiple)-495.5(cell)-490.8(types)-484.7(generated)-492.7(from)-489.4(the)-494.2(same)-485.8(source,)-496(and)]TJ
0 -1.1174 TD
[(genet)-8(ic)-331.8(modication)-338.5(as)-331.5(needed.)]TJ
1.0137 -1.1116 TD
.0188 Tc
[(As)-437.1(cell)-5.5(s)-431.4(un)-5.3(derg)-5.3(o)-431.6(s).6(p)-5.3(eci)-5.2(cat)-5.5(ion)-431.5(i)-5.5(nto)-431.6(c)-6.5(hond)-5.3(rog)-5.3(e)-.7(nic)-6.5(,)-428.1(o)-5.3(s).6(-)]TJ
-1.0137 -1.1116 TD
.0186 Tc
[(t)-5.7(e)-.9(og)-5.5(enic)-6.7(,)-820(a)-.9(nd)-823.4(s)-5.3(t).1(rom)-6.8(a)-.9(l)-823.5(line)-6.7(a)-.9(ges)-5.3(,)-820(th)-5.5(eir)-823.4(d).2(i)-5.7(f).3(fer)-5.5(e)-.9(nt)-5.7(iat)-5.7(i).1(on)]TJ
0 -1.1174 TD
.0201 Tc
[(should)-476.3(not)-470.7(b)-4(e)-477.5(done)-471.7(i)-4.2(n)-476.3(i)1.6(solati)]TJ
12.9478 0 TD
.0199 Tc
[(on)-476.5(to)-476.5(recapitulate)-477.7(physio-)]TJ
-12.9478 -1.1116 TD
.0187 Tc
[(l)-5.6(ogi)-5.6(cal)-581.5(deve)-6.6(lop)-5.4(m)-.9(ent)-5.6(a)-.8(l)-575.8(p).3(r)-5.4(o).3(ce)-6.6(sse)-6.6(s)-575.5(w)-.5(i)-5.6(t).2(h)-575.6(i)-5.6(nter)-5.4(tis)-5.2(sue)-582.6(c)-.8(ro)-5.4(ss)]TJ
T*
.0228 Tc
[(tal)4.3(k)-398.8(an)4.4(d)-398.8(r)4.5(esp)4.4(o)4.4(n)-1.3(s)4.6(i)4.3(ven)4.4(e)3.3(ss)-398.6(t)4.3(o)-398.8(st)4.3(i)4.3(m)3.2(ul)4.3(i)-398.9([)4.5(11)4.4(])4.5(.)-401.1(F)4.6(u)4.4(rt)4.3(h)4.4(e)-2.5(r)-398.7(m)3.2(at)4.3(ur)4.5(a-)]TJ
T*
.0186 Tc
[(t)-5.7(i).1(on)-374.2(of)-374.1(bioe)-6.7(ngi)-5.7(neer)-5.5(ed)-368.4(c)-6.7(a)-.9(rt)-5.7(ilag)-5.5(e)-.9(b)-5.5(one)-375.3(tis)-5.3(sue)-6.7(s)-368.2(wi)-5.7(ll)-368.5(r)-5.5(e)-.9(qu)-5.5(ire)]TJ
0 -1.1174 TD
.0202 Tc
[(spatiotemporal)-395.7(spec)-5.1(ic)-5.1(a).7(tion)-395.6(o)1.8(f)-395.6(g)-3.9(row)-4.8(t)1.7(h)-395.6(f)1.9(a)-5.1(c).7(tors)-395.4(and)-395.6(o)1.8(ther)]TJ
0 -1.1116 TD
.0206 Tc
[(c)-4.7(u)2.2(es.)-345.7(F)2.4(inally,)-351.4(r)2.3(eliable)-350.3(m)1(et)]TJ
11.1853 0 TD
.0187 Tc
[(h)-5.4(ods)-350.8(to)-351(i)-5.6(ndu)-5.4(ce)-352.2(and)-351(b).3(e)-6.6(n).3(chm)-6.7(a)-.8(rk)]TJ
-11.1853 -1.1116 TD
.3996 Tc
[(t)375.3(h)381.2(eO)374.6(Ad)381.2(i)375.3(s)381.4(e)380.1(a)374.3(s)381.4(e)-.1(s)375.7(t)381.1(a)380.1(t)375.3(ef)381.3(r)375.5(o)381.2(ms)375.7(t)381.1(a)380.1(b)381.2(l)375.3(ea)380.1(n)375.5(d)1.1(m)380(a)380.1(t)375.3(u)381.2(r)381.3(e)-5.8(e)380.1(n)381.2(g)381.2(i)375.3(n)381.2(e)380.1(e)374.3(r)381.3(e)380.1(d)]TJ
0 -1.1174 TD
.0187 Tc
[(t)-5.6(i).2(ss)-5.2(ue)-334.9(mo)-5.4(del)-5.6(s)-333.5(are)-334.9(r)-5.4(equ)-5.4(i).2(re)-6.6(d.)]TJ
/F6 1 Tf
9.9626 0 0 9.9626 313.0582 153.9212 Tm
0 Tc
[(Chon)-12.1(drogen)-9.9(ic)-333.6(Fate)-339(Specic)-10.1(ation)]TJ
/F4 1 Tf
9.843 0 0 9.843 323.0361 133.5685 Tm
[(Starting)-476.7(from)-472.1(hiPSCs)-473.8(and)-476.8(other)-473.3(pluripotent)-474.5(stem)-473.3(cells,)]TJ
-1.0137 -1.1116 TD
[(approaches)-522.3(for)-521.6(differentiation)-521.7(into)-517.3(the)-517.2(relevant)-519.4(musculo-)]TJ
0 -1.1174 TD
[(skeletal)-381.1(lineages)-381(can)-380(be)-377.7(classied)-381.7(broadly)-377.6(into)-373.3(single-step,)]TJ
0 -1.1116 TD
[(MSC-based,)-731.4(and)-730.2(developmentally)-731.4(guided)-727.9(protocols.)-728.8(In)]TJ
T*
[(choosi)-7.7(ng)-555.1(an)-562.1(approach)-559.4(for)-561.9(generating)-561.9(chondrocytes)-563.8(from)]TJ
T*
[(hiPSCs,)-442.7(the)-436.6(fundamental)-443.3(issue)-438.4(of)-439.9(how)-436.1(simple)-441(is)-434.1(complex)]TJ
0 -1.1174 TD
[(enough)-330.3(will)-328.2(determine)-331.6(how)-326.7(much)-329.3(development)-328.1(needs)-330.2(to)-324.9(be)]TJ
0 -1.1116 TD
[(recap)-9(itulated)-633.7(and)-632.3(how)-632(much)-634.6(cell)-634.8(heterogeneity)-635.6(can)-633.4(be)]TJ
/F6 1 Tf
8.9663 0 0 8.9663 62.022 749.6502 Tm
(2)Tj
39.7016 0 TD
[(WU)-333(AND)-337.2(VUNJAK-NOVAKOVIC)]TJ
ET
endstream
endobj
35 0 obj
<>stream
hd}Luap]SV%cC^&CYJ+PJJ[J
ư/:] cq%hnjQ0Oo&<8yyE92kl<"(zʈ؞"ݽ.?gzA"
2Rۓ~!5/=Ьfer9:c-H2o:h2Zץs\Nc#W qċQ7z/qi9YxVsS([Lc),qwQҏ9WjX*zzWLհTdPnmw]B+* Á7 AHް_LkW"jR/Kl&sYgs,lkAlCT kQnTD&?KwLKSΠ"2$ %ʴ5EVxxfZUD~vqI@'nӝ4' q{Xj
0E{ehWEoc][^(S?;T!9: *RPF?,O(8 ϟ߬jP:zƢgQ(TMR=HD:1͊rqx6h_XSجrD$bb=:q
lGIrX"(=> s[e>|;eH^daW[u<ǓE' /Б
endstream
endobj
37 0 obj
<>stream
hlRmLeݦٵKh[EPiA`|+=ja{Pk[
j!i5kM#%`HMl&jy33LBY WXhe-N(RֲY7aӃV$ۗ
~E9ӫ2Ĭݻ^9gsmno$:OjP}*U\>ɽCmbZU,TIi1IeUt>\J7JHtyxQ6JUv.E,BXLA%QF
Dy"@D91nJ[Vuܺ!muh',6f3j3Gy
^Q8 rc'pj>yi{=BX?7|D(G@65q1oi>|
稸ks
l&[\osf1L+ix8x=K |ho;Jy:idy:6
9l,&p5dGú Pl`Z#z e!)wa^!
MwGY pSh|oȨe o
$3Ǩچ&*"}$g"jFvD;xTL.-&T3
[L@& '))8'++H)%H=iM9A.>FBNɃOq